EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Patient Characteristics, Diagnostic Testing Utilization, and Antifungal Prescribing Pattern for Onychomycosis in the USA: A Cohort Study Using DataDerm, 2016–2022

Aditya K. Gupta, Tong Wang, Anh N. Tran

Skin Appendage Disorders · 2024-08-29 · 1-9

DOI: 10.1159/000540704 ↗
AbstractBibliografische Angaben

Abstract

Introduction: Onychomycosis is a complex nail disease that is commonly seen in daily practice. Methods: Electronic health records of clinically diagnosed onychomycosis patients were extracted using DataDerm – a dermatology data registry hosted by the American Academy of Dermatology – spanning from the year 2016 to 2022. Results: Regardless of age, an increasing trend in patient volume was observed in the Southern US region, which accounted for 50.7–56.9% of onychomycosis patients in 2022. A coinfection of tinea pedis was present among 15.6–22.5% of patients. Diagnostic testing was infrequently utilized with less than one-quarter of patients having a histopathologic examination (12.7–21.9%) followed by fungal culture (5.5–8.2%) and direct microscopic examination (3.3–6.0%). Treatments were infrequently prescribed, accounting for less than one-quarter of patients (orals, terbinafine: 20.8–29.1%, fluconazole: 12.9–16.5%; topicals, efinaconazole: 3.2–13.8%); over 30% of treated patients received a combination regimen or experienced switching of treatments. Prescribing patterns did not significantly differ in vulnerable patient groups such as elderly patients and in patients with concomitant tinea pedis. Patients receiving a topical and/or oral antifungal prescription were frequently not tested to confirm the onychomycosis diagnosis (76.9%). Conclusion: Our findings add to a growing body of literature calling for the improvement of onychomycosis management practices.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →